Insiders Pulse Biosciences, Inc.

Equities

PLSE

US74587B1017

Real-time Estimate Cboe BZX Other stock markets 20:16:22 14/05/2024 BST			5-day change	1st Jan Change
7.525 ^USD	+5.24%		-1.18%	-38.64%

05-09	Pulse Biosciences, Inc. Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System	CI
05-07	Transcript : Pulse Biosciences, Inc., Q1 2024 Earnings Call, May 07, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pulse Biosciences Insider Bought Shares Worth $843,504, According to a Recent SEC Filing	12-14	MT
Pulse Biosciences Insider Bought Shares Worth $1,117,085, According to a Recent SEC Filing	12-01	MT
Pulse Biosciences Insider Bought Shares Worth $123,470, According to a Recent SEC Filing	11-21	MT
Pulse Biosciences, Inc. Appoints Dr. Niv Ad as Chief Science Officer, Cardiac Surgery	24/10/23	CI
Pulse Biosciences, Inc. Announces Board Changes	30/05/23	CI
Insider Buy: Pulse Biosciences	10/05/23	MT
Pulse Biosciences, Inc. Appoints f Gansevoort 'Gan' Dunnington, M.D. as Its Chief Medical Officer	04/05/23	CI
Pulse Biosciences, Inc. Appoints Manmeet S. Soni as Lead Independent Director	30/03/23	CI
Anebulo Pharmaceuticals Appoints Sandra Gardiner as Acting Chief Financial Officer	08/03/23	MT
Pulse Biosciences, Inc. Announces Resignation of Sandra Gardiner as Chief Financial Officer	06/12/22	CI
Pulse Biosciences Names New CEO; Board Chair Makes $65 Million Loan to Boost Product Development	20/09/22	MT
Pulse Biosciences, Inc. Announces Executive Changes	20/09/22	CI
Pulse Biosciences, Inc. Announces Chief Executive Officer Changes	20/09/22	CI
Pulse Biosciences, Inc. Announces Resignation of Ed Ebbers as Executive Vice President and General Manager of Dermatology	21/03/22	CI
Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer	15/02/22	CI
Pulse Biosciences, Inc. Announces Executive Changes	24/11/21	CI
Pulse Biosciences Appoints Laureen DeBuono to Its Board of Directors	05/10/21	CI
Pulse Biosciences Announces Appointment of Mitchell E. Levinson as Chief Strategy Officer	19/08/21	CI
Pulse Biosciences, Inc. Appoints Richard van den Broek to its Board of Directors	06/08/20	CI
Pulse Biosciences, Inc. Announces Resignation of Thomas J. Fogarty from the Board of Directors	19/12/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Pulse Biosciences, Inc.

Equities

PLSE

US74587B1017

Insiders

Filters